Cite
Erbe R, Wang Z, Wu S, et al. Evaluating the impact of age on immune checkpoint therapy biomarkers. Cell Rep. 2021;37(7):110033doi: 10.1016/j.celrep.2021.110033.
Erbe, R., Wang, Z., Wu, S., Xiu, J., Zaidi, N., La, J., Tuck, D., Fillmore, N., Giraldo, N. A., Topper, M., Baylin, S., Lippman, M., Isaacs, C., Basho, R., Serebriiskii, I., Lenz, H. J., Astsaturov, I., Marshall, J., Taverna, J., Lee, J., Jaffee, E. M., Roussos Torres, E. T., Weeraratna, A., Easwaran, H., & Fertig, E. J. (2021). Evaluating the impact of age on immune checkpoint therapy biomarkers. Cell reports, 37(7), 110033. https://doi.org/10.1016/j.celrep.2021.110033
Erbe, Rossin, et al. "Evaluating the impact of age on immune checkpoint therapy biomarkers." Cell reports vol. 37,7 (2021): 110033. doi: https://doi.org/10.1016/j.celrep.2021.110033
Erbe R, Wang Z, Wu S, Xiu J, Zaidi N, La J, Tuck D, Fillmore N, Giraldo NA, Topper M, Baylin S, Lippman M, Isaacs C, Basho R, Serebriiskii I, Lenz HJ, Astsaturov I, Marshall J, Taverna J, Lee J, Jaffee EM, Roussos Torres ET, Weeraratna A, Easwaran H, Fertig EJ. Evaluating the impact of age on immune checkpoint therapy biomarkers. Cell Rep. 2021 Nov 16;37(7):110033. doi: 10.1016/j.celrep.2021.110033. PMID: 34788629.
Copy
Download .nbib